Page last updated: 2024-08-23

daunorubicin and purvalanol a

daunorubicin has been researched along with purvalanol a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ceckova, M; Cihalova, D; Hofman, J; Staud, F	1

Other Studies

1 other study(ies) available for daunorubicin and purvalanol a

Article	Year
Purvalanol A, olomoucine II and roscovitine inhibit ABCB1 transporter and synergistically potentiate cytotoxic effects of daunorubicin in vitro. PloS one, 2013, Volume: 8, Issue:12 Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line; Cell Membrane; Cell Proliferation; Cyclin-Dependent Kinases; Daunorubicin; Drug Synergism; Gene Expression Regulation; Humans; Protein Kinase Inhibitors; Purines; RNA, Messenger; Roscovitine	2013

Article

Year

Purvalanol A, olomoucine II and roscovitine inhibit ABCB1 transporter and synergistically potentiate cytotoxic effects of daunorubicin in vitro.

PloS one, 2013, Volume: 8, Issue:12

Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line; Cell Membrane; Cell Proliferation; Cyclin-Dependent Kinases; Daunorubicin; Drug Synergism; Gene Expression Regulation; Humans; Protein Kinase Inhibitors; Purines; RNA, Messenger; Roscovitine

2013